Common pathophysiological background includes: (a) risk factors such as aging, obesity and physical inactivity; (b) biological processes including hyperinsulinemia, hyperglycemia, oxidative stress and chronic low-grade inflammation and (c) molecular pathways such as the insulin/insulin-like growth factor (IGF) and interleukin (IL)-6/signal transducer and activator of transcription 3 (STAT3) axes [5]. This evidence concerns the gene STAT3 and obesity disorder.